COMPAZINE
LOE ApproachingNDAORALCAPSULE, EXTENDED RELEASE
Approved
Oct 1999
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 16h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
COMPAZINE (prochlorperazine) is an oral extended-release capsule approved in 1999 for managing nausea, vomiting, and psychiatric symptoms. As a typical antipsychotic and antiemetic small molecule, it works via dopamine antagonism in the chemoreceptor trigger zone and vomiting center. The drug treats patients across multiple therapeutic areas including post-operative nausea, migraines, and behavioral/psychiatric conditions.
LOE Approaching
With LOE approaching and moderate competitive pressure (30/100), the brand team is likely consolidating resources and shifting focus toward lifecycle extension or preparation for generic transition.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
With zero linked job openings and LOE approaching, COMPAZINE offers limited entry or growth opportunities. Roles on this asset are typically focused on managing decline, optimizing operations, and preparing transition strategies rather than launching or scaling.
Brand ManagerCommercial Lead
Worked on COMPAZINE at GSK? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.